Serum Levels of M2BPGi as Short-Term Predictors of Hepatocellular Carcinoma in Untreated Chronic Hepatitis B Patients
Autor: | Li Yu Wang, Masashi Mizokami, Hwai I. Yang, Masaaki Korenaga, Sheng Nan Lu, Chin Lan Jen, Jessica Liu, Richard Batrla-Utermann, Mei Hsuan Lee, Chien-Jen Chen, Hui Han Hu |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2017 |
Předmět: |
Adult
Liver Cirrhosis Male medicine.medical_specialty HBsAg Carcinoma Hepatocellular lcsh:Medicine Logistic regression Antiviral Agents Gastroenterology Article 03 medical and health sciences Hepatitis B Chronic 0302 clinical medicine Antigen Chronic hepatitis Antigens Neoplasm Internal medicine Biomarkers Tumor Carcinoma medicine Humans lcsh:Science neoplasms Aged Glycoproteins Hepatitis B Surface Antigens Multidisciplinary business.industry Liver Neoplasms lcsh:R Case-control study Middle Aged Hepatitis B Prognosis medicine.disease digestive system diseases ROC Curve Area Under Curve Case-Control Studies 030220 oncology & carcinogenesis Hepatocellular carcinoma Female 030211 gastroenterology & hepatology lcsh:Q alpha-Fetoproteins Carrier Proteins business |
Zdroj: | Scientific Reports, Vol 7, Iss 1, Pp 1-10 (2017) Scientific Reports |
ISSN: | 2045-2322 |
DOI: | 10.1038/s41598-017-14747-5 |
Popis: | This study examines the role of M2BPGi, a novel seromarker for chronic hepatitis, in predicting hepatocellular carcinoma (HCC) among untreated chronic hepatitis B (CHB) patients. In this nested case-control study, 1070 samples were assayed for M2BPGi, including 357 samples from HCC cases, and 713 samples from non-HCC controls, collected at various times throughout follow-up. HCC case samples were stratified according to years prior to diagnosis. Associations between M2BPGi and HCC were examined with multivariate logistic regression. M2BPGi, α-fetoprotein (AFP), and hepatitis B surface antigen (HBsAg) levels were significant independent short-term predictors of HCC, while M2BPGi was insignificant in long-term analyses. Compared to M2BPGi levels 5 years were 0.84, 0.81, and 0.75. M2BPGi is a strong and independent short-term predictor of HCC in CHB patients. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |